127 related articles for article (PubMed ID: 36807382)
21. Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair.
He X; Zhang P
Mol Cancer; 2015 Aug; 14():158. PubMed ID: 26282282
[TBL] [Abstract][Full Text] [Related]
22. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
23. SRSF6 regulates alternative splicing of genes involved in DNA damage response and DNA repair in HeLa cells.
Yang X; Zhan P; Feng S; Ji H; Tian W; Wang M; Cheng C; Song B
Oncol Rep; 2020 Nov; 44(5):1851-1862. PubMed ID: 32901876
[TBL] [Abstract][Full Text] [Related]
24. Truncated serine/arginine-rich splicing factor 3 accelerates cell growth through up-regulating c-Jun expression.
Kano S; Nishida K; Nishiyama C; Akaike Y; Kajita K; Kurokawa K; Masuda K; Kuwano Y; Tanahashi T; Rokutan K
J Med Invest; 2013; 60(3-4):228-35. PubMed ID: 24190040
[TBL] [Abstract][Full Text] [Related]
25. Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3.
Ke H; Zhao L; Zhang H; Feng X; Xu H; Hao J; Wang S; Yang Q; Zou L; Su X; Wang L; Wu C; Wang Y; Nie J; Jiao B
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3426-E3435. PubMed ID: 29581274
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO.
Yang P; Chen T; Xu Z; Zhu H; Wang J; He Z
Oncotarget; 2016 Jul; 7(27):42183-42194. PubMed ID: 27259250
[TBL] [Abstract][Full Text] [Related]
27. The RNA-binding profile of the splicing factor SRSF6 in immortalized human pancreatic β-cells.
Alvelos MI; Brüggemann M; Sutandy FR; Juan-Mateu J; Colli ML; Busch A; Lopes M; Castela Â; Aartsma-Rus A; König J; Zarnack K; Eizirik DL
Life Sci Alliance; 2021 Mar; 4(3):. PubMed ID: 33376132
[TBL] [Abstract][Full Text] [Related]
28. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
29. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers.
Cohen-Eliav M; Golan-Gerstl R; Siegfried Z; Andersen CL; Thorsen K; Ørntoft TF; Mu D; Karni R
J Pathol; 2013 Mar; 229(4):630-9. PubMed ID: 23132731
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.
Jia R; Ajiro M; Yu L; McCoy P; Zheng ZM
RNA; 2019 May; 25(5):630-644. PubMed ID: 30796096
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic SRSF3 in health and diseases.
Jia R; Zheng ZM
Int J Biol Sci; 2023; 19(10):3057-3076. PubMed ID: 37416784
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic lncRNA ZNFX1 antisense RNA 1 promotes osteosarcoma cells proliferation and metastasis by stabilizing serine and arginine‑rich splicing factor 3.
Zhang Y; Xu W; Wang Y; Li J; He G; Guan M; Zeng X; Bian W; Song Y; Liu J
Bioengineered; 2022 Mar; 13(3):5962-5974. PubMed ID: 35184675
[TBL] [Abstract][Full Text] [Related]
33. Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.
de Miranda NF; van Dinther M; van den Akker BE; van Wezel T; ten Dijke P; Morreau H
Gastroenterology; 2015 Jun; 148(7):1427-37.e8. PubMed ID: 25736321
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
[TBL] [Abstract][Full Text] [Related]
35. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
36. SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.
Gautrey H; Jackson C; Dittrich AL; Browell D; Lennard T; Tyson-Capper A
RNA Biol; 2015; 12(10):1139-51. PubMed ID: 26367347
[TBL] [Abstract][Full Text] [Related]
37. The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68.
Wang X; Yu H; Sun W; Kong J; Zhang L; Tang J; Wang J; Xu E; Lai M; Zhang H
Mol Cancer; 2018 Jul; 17(1):110. PubMed ID: 30064438
[TBL] [Abstract][Full Text] [Related]
38. Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5.
Che Y; Bai M; Lu K; Fu L
Mol Carcinog; 2023 Feb; 62(2):210-223. PubMed ID: 36282044
[TBL] [Abstract][Full Text] [Related]
39. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer.
Wang W; Xing C
Pathol Res Pract; 2016 Aug; 212(8):690-5. PubMed ID: 27461828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
